Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01119196 · ClinicalTrials.gov registry record · NA
The Measurement of Insulin Resistance in Peritoneal Dialysis Patients
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01119196 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 10 participants.
The verdict
NCT01119196, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The goal of this study is to examine the relevance of insulin resistance in peritoneal dialysis (PD) patients as well as the means to improve this metabolic derangement. We will do so through a prospective randomized study using Icodextrin as an alternate dialysate solution to routine glucose-based dialysate. We hypothesize that (1) the glucose loading associated with PD leads to impairment in insulin sensitivity, (2) the degree of insulin resistance is dependent on the basal metabolic state (fasting versus stimulated), and (3) the replacement of conventional dialysate with glucose-sparing dialysate preparations will improve insulin resistance and associated metabolic disturbances in PD patients.
Interventions
- OTHER Icodextrin dialysate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2010-09 |
| Est. Completion | 2015-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01119196
The ClinicalTrials.gov registry entry for NCT01119196 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Icodextrin dialysate is the first listed.
NCT01119196 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01119196 about?
NCT01119196 is a clinical study titled "The Measurement of Insulin Resistance in Peritoneal Dialysis Patients". The goal of this study is to examine the relevance of insulin resistance in peritoneal dialysis (PD) patients as well as the means to improve this metabolic derangement. We will do so through a prospective randomized study using Icodextrin as an alternate dialysate solution to routine glucose-based ...
What is the current status of trial NCT01119196?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2010-09. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01119196?
The interventions under investigation include: Icodextrin dialysate (OTHER).
Who is sponsoring clinical trial NCT01119196?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.